Last updated: 2026-09-16 00:40:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $267.11, with a market capitalisation of $640.02B and a P/E ratio of 30.51. Over the past 52 weeks, its price has ranged from $173.33 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$640.02B | |
$265.81 | |
$281.07 | |
$46.25 | |
$266.32 | |
3.75M | |
7.64M | |
30.51 | |
$281.07 | |
$173.33 | |
1.97% | |
-- |
Johnson & Johnson (JNJ) last closed at $266.32 as of 2026-09-16 00:00:00, unchanged from the previous close of $266.32.
During the latest regular trading session, JNJ traded between $46.25 and $281.07, with a volume of 3.75M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $278.43 to $267.11, representing a decline of 4.07% ($11.32).
The stock traded between $260.78 and $278.89 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 5.55 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 87.0%
JNJ is currently trading at $267.11, placing it 87.0% of the way from its 52-week low of $173.33 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.